Jpmorgan Chase & CO Biote Corp. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Biote Corp. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 58,517 shares of BTMD stock, worth $255,719. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,517
Previous 17,431
235.71%
Holding current value
$255,719
Previous $97,000
277.32%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BTMD
# of Institutions
91Shares Held
18.6MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$19.9 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$10.6 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$7.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$6.25 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$5.91 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $33.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...